HALISTER: Merck’s Ebola Vaccine Shows 100% Efficacy in Trial, WHO Says

Merck’s Ebola Vaccine Shows 100% Efficacy in Trial, WHO Says

Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
MRK US (Merck & Co Inc)
NLNK US (NewLink Genetics Corp)
0751538D SW (World Health Organization)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283